Giuseppe Calà

Giuseppe Calà

Auto-generated profile, based on publicly available information

Giuseppe Calà

Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MGMattia Francesco Maria Gerli
Mattia Francesco Maria Gerli
GCGiuseppe Calà
Giuseppe Calà
MBMax Arran Beesley
Max Arran Beesley
BSBeatrice Sina
Beatrice Sina
LTLucinda Tullie
Lucinda Tullie
PCPaolo De Coppi
Paolo De Coppi
Isolation of tissue-specific fetal stem cells and derivation of primary organoids is limited to samples obtained from termination of pregnancies, hampering prenatal investigation of fetal development and congenital diseases. Therefore, new patient-specific in vitro models are needed. To this aim, isolation and expansion of fetal stem cells during pregnancy, without the need for tissue samples or reprogramming, would be advantageous. Amniotic fluid (AF) is a source of cells from multiple developing organs. Using single-cell analysis, we characterized the cellular identities present in human AF. We identified and isolated viable epithelial stem/progenitor cells of fetal gastrointestinal, renal and pulmonary origin. Upon culture, these cells formed clonal epithelial organoids, manifesting small intestine, kidney tubule and lung identity. AF organoids exhibit transcriptomic, protein expression and functional features of their tissue of origin. With relevance for prenatal disease modeling, we derived lung organoids from AF and tracheal fluid cells of congenital diaphragmatic hernia fetuses, recapitulating some features of the disease. AF organoids are derived in a timeline compatible with prenatal intervention, potentially allowing investigation of therapeutic tools and regenerative medicine strategies personalized to the fetus at clinically relevant developmental stages.

23 January 2026 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
BJBrendan C. Jones
Brendan C. Jones
GBGiada Benedetti
Giada Benedetti
GCGiuseppe Calà
Giuseppe Calà
RARamin Amiri
Ramin Amiri
LTLucinda Tullie
Lucinda Tullie
PCPaolo De Coppi
Paolo De Coppi
Patient-derived human organoids have the capacity to self-organize into more complex structures. However, to what extent gastric organoids can recapitulate differentiated cell types and mucosal functions remains unexplored. Here we report on how region-specific gastric organoids can self-assemble into complex multi-regional assembloids. These assembloids show increased complexity and cross-communication between different gastric regions, allowing for the emergence of the elusive parietal cell type that is responsible for the production of gastric acid and shows a functional response to drugs targeting the H + /K + ATPase pump. We generate assembloids from paediatric patients with a genetic condition found to be associated with unusual antral foveolar hyperplasia and hyperplastic polyposis. Our multi-regional assembloid efficiently recapitulates hyperplastic-like antral regions, with decreased mucin secretion and glycosylated H + /K + ATPase subunit beta, which results in impaired gastric acid secretion. Multi-regional gastric assembloids, generated using paediatric-stem-cell-derived organoids, successfully recapitulate the structural and functional characteristics of the human stomach, offering a promising tool for studying gastric epithelial interactions and disease mechanisms that were previously challenging to investigate in primary models.

14 August 2025 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
GCGiuseppe Calà
Giuseppe Calà
GDGiorgia D’ARiano
Giorgia D’ARiano
KSKylin Yunyan Sun
Kylin Yunyan Sun
GZGloria Ji Zhang
Gloria Ji Zhang
GCGiuseppe Matteo Carrino
Giuseppe Matteo Carrino
MGMattia Francesco Maria Gerli
Mattia Francesco Maria Gerli

1 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MGMattia Francesco Maria Gerli
Mattia Francesco Maria Gerli
GCGiuseppe Calà
Giuseppe Calà
MBMax Arran Beesley
Max Arran Beesley
BSBeatrice Sina
Beatrice Sina
LTLucinda Tullie
Lucinda Tullie
PCPaolo De Coppi
Paolo De Coppi
Despite advances in prenatal diagnosis, it is still difficult to predict severity and outcomes of many congenital malformations. New patient-specific prenatal disease modelling may optimise personalised prediction. We and others have described the presence of mesenchymal stem cells in amniotic fluid (AFSC) that can generate induced pluripotent stem cells (iPSCs). The lengthy reprogramming processes, however, limits the ability to define individual phenotypes or plan prenatal treatment. Therefore, it would be advantageous if fetal stem cells could be obtained during pregnancy and expanded without reprogramming. Using single cell analysis, we characterised the cellular identities in amniotic fluid (AF) and identified viable epithelial stem/progenitor cells of fetal intestinal, renal and pulmonary origin. With relevance for prenatal disease modelling, these cells could be cultured to form clonal epithelial organoids manifesting small intestine, kidney and lung identity. To confirm this, we derived lung organoids from AF and tracheal fluid (TF) cells of Congenital Diaphragmatic Hernia (CDH) fetuses and found that they show differences to non-CDH controls and can recapitulate some pathological features of the disease. Amniotic Fluid Organoids (AFO) allow investigation of fetal epithelial tissues at clinically relevant developmental stages and may enable the development of therapeutic tools tailored to the fetus, as well as to predicting the effects of such therapies.

9 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
GDGiorgia D’Ariano
Giorgia D’Ariano
GZGloria Ji Zhang
Gloria Ji Zhang
GCGiuseppe Calà
Giuseppe Calà
GCGiuseppe Matteo Carrino
Giuseppe Matteo Carrino
AAAeshna Agarwal
Aeshna Agarwal
MGMattia Francesco Maria Gerli
Mattia Francesco Maria Gerli
Primary fetal human epithelial organoids are canonically derived from tissue samples obtained after termination of pregnancy. Recently, we have demonstrated that these organoids can be consistently generated from amniotic fluid cells isolated prenatally during diagnostic and interventional procedures. Amniotic Fluid-derived Organoids (AFOs) are promising fetal epithelial lung, kidney and small intestine tissue models that bypass some of the ethical and legal constraints associated with obtaining primary fetal tissue. Despite this, the widespread adoption of this technology is limited by the lack of standardised and accessible pipelines for the biobanking, culturing and distribution of organoid-forming amniotic fluid cells. To enable broader AFO use for research and clinical purposes, this work investigates two cryopreservation strategies to optimise AF cell recovery for organoid derivation. In Strategy 1, viable AF cells were sorted before freezing, while in Strategy 2 unsorted AF was frozen, and viable AF cells were sorted for viability after thawing. We present here a comprehensive evaluation of 5 commercially available GMP-compliant freezing media (FM1-5) alongside a standard lab-grade control (FM CT). AFOs were assessed for formation efficiency, morphological characteristics, proliferation capacity, epithelial identity, and tissue type. Our results demonstrate that organoid-forming AF cells can be successfully cryopreserved both pre-and post-sorting. Strategy 1 yielded higher organoid formation efficiency, with AFOs derived from cryopreserved and fresh cells exhibiting comparable expansion potential. Finally, FM4 provided minimal to no decline in survival rate, making it the most effective GMP-grade freezing medium tested. In conclusion, we present two viable cryopreservation strategies adaptable to different laboratory settings and identify optimal GMP-compliant freezing media, to support safe distribution and centralised processing, thereby facilitating scalability and collaborative work on the AFO technology. HIGHLIGHTS: Cryopreserved AF cells efficiently generate primary fetal epithelial organoids (AFOs) Live cell sorting conducted before cryopreservation retains AFO formation efficiency GMP-compliant freezing media show different AF cells cryopreservation ability AFOs from cryopreserved AF cells expand well, and retain tissue-specific phenotype

11 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BJBrendan C Jones
Brendan C Jones
GBGiada Benedetti
Giada Benedetti
GCGiuseppe Calà
Giuseppe Calà
LTLucinda Tullie
Lucinda Tullie
ISIan C Simcock
Ian C Simcock
PCPaolo De Coppi
Paolo De Coppi
Patient-derived human organoids have the remarkable capacity to self-organise into more complex structures. However, to what extent gastric organoids can recapitulate human stomach physiological functions remain unexplored. Here, we report how region-specific gastric organoids can self-assemble into complex multi-regional assembloids showing functional response to drugs targeting the ATPase H+/K+ pump. The assembloids show preserved fundus, body, and antrum regional identity, and gastric-specific crosstalk pathways arise. The increased complexity and cross-communication between the different gastric regions, allow for the emergence of the elusive parietal cell type, responsible for the production of gastric acid, with functional response to drugs targeting the ATPase H+/K+ pump. Remarkably, we generated assembloids from PMM2-HIPKD-IBD paediatric patients (Phosphomannomutase 2 – Hyperinsulinemic hypoglycaemia and autosomal recessive polycystic kidney disease - Inflammatory bowel disease), a genetic condition found to be associated with unusual antral foveolar hyperplasia and hyperplastic polyposis. The cellular mechanisms behind such phenomena are poorly understood, and an exhaustive experimental model is needed. The ΔPMM2 multi-regional assembloid we have generated efficiently recapitulates hyperplastic-like antral regions, with decreased mucin secretion and glycosylated ATP4b, which results in impaired gastric acid secretion. Multi-regional gastric assembloids, generated using adult-stem cell-derived organoids, successfully recapitulate the structural and functional characteristics of the human stomach, offering a promising tool for studying gastric epithelial interactions and disease mechanisms previously challenging to investigate in primary models.